Office Apocalypse

Chapter 75: The Veterinarian's Friend

Quick Verification

Please complete the check below to continue reading. This helps us protect our content.

Loading verification...

Dr. Linda Yamamoto arrived at the Valley Rest Inn at 9:47 PM in a silver Prius with a UC Davis faculty parking sticker and a bumper sticker that read SPAY AND NEUTER YOUR POLITICIANS.

Kevin watched her park from the motel window. She was small -- five-two, maybe five-three -- with short gray-streaked black hair and the kind of glasses that academics wore when they wanted to look serious and that everyone else wore when they wanted to look like academics. She got out of the Prius, looked at the motel, looked at the room number Paul had given her, and walked toward them with the brisk stride of a woman who made decisions quickly and implemented them faster.

Paul opened the door before she knocked. Linda Yamamoto looked at Paul Okafor, and her face did something that Kevin recognized -- the rearrangement of features that happened when a person saw someone they'd assumed was dead walking around alive. Not joy exactly. Not relief exactly. The thing between the two that hadn't been named because English didn't have enough words for the variations of glad.

"You look terrible," she said.

"I've been eating Purina One for two weeks."

"That would do it." She stepped inside. Her eyes swept the room the way a professor's eyes swept a classroom -- taking inventory, assessing the population, measuring the gap between what she'd been told and what she was seeing. Nine people. Tired. Thin. Armed, some of them, the weapons visible because the group had stopped hiding them after the police station because hiding things from allies was a luxury they could no longer afford.

Her gaze landed on Kevin's brace. On Karen's axe, leaning against the wall. On Marcus's laptop, its screen dark, conserving its dying battery for the moment it mattered. On Derek, who was sitting on the adjoining room's bed with a chocolate lab in his lap and a German shepherd at his feet and the expression of a man who'd given up pretending he wasn't a dog person.

"Paul," Linda said. "On the phone you said 'zombie virus.' I drove here because I've known you for fifteen years and you don't use words carelessly. But I need to hear the explanation that makes that phrase something other than what it sounds like."

"Sit down," Paul said.

"I'll stand."

"You should sit."

"Paul."

"Linda. Sit down."

She sat. The chair by the desk, Marcus scooting aside to give her space. She sat the way scientists sat when they were about to hear data -- forward, weight on her elbows, chin slightly raised, the posture of active listening.

Kevin told her. Not the full version -- there wasn't time for the full version, and the full version would take longer than her willingness to listen without evidence. The executive summary. BioVance. LZR-7. The pathogen that reanimated dead tissue while preserving motor function. The Meridian connection. The deployment zones. The northern outbreak that the news was calling a chemical spill. The convoy heading south. Mather Field. The fifty-eight-hour countdown that was now closer to forty-six.

He told it straight. No analogies. No softening. The facts, delivered in the order they'd been discovered, the way a developer would walk a colleague through a bug report -- here's the error, here's the reproduction steps, here's the cascade failure.

Linda Yamamoto listened. Her face went through stages. Kevin had seen those stages before -- on Paul's face, on every face that received this information for the first time. The denial stage, where the features tightened and the eyes narrowed. The consideration stage, where the features relaxed as the brain engaged. The acceptance stage, which wasn't acceptance of the truth but acceptance of the possibility of the truth, which was enough.

"The pathogen," she said. "The mechanism. You're describing a prion-like agent that maintains neural motor function while destroying higher brain activity?"

Kevin looked at Paul. Paul had gone clinical -- the posture shift of a medical professional hearing medical language and responding in kind.

"Based on what I observed in Greenfield," Paul said, "the infected retain ambulatory function. Coordination varies -- some move with near-normal gait, others are degraded. They respond to auditory and visual stimuli. They don't appear to respond to verbal communication. The aggressive behavior is consistent across all subjects I observed -- stimulus-driven, directed, persistent."

"How many subjects?"

"Seven visible on the street over two weeks. Plus two in my ground floor that I could hear but not see. The auditory data suggests limited motor planning -- they could navigate a space they'd been in before, but couldn't problem-solve past a barricade."

"Incubation period?"

"Unknown from my observation window. The infected in my building were already turned when I barricaded. Kevin -- what's the data say?"

Kevin looked at Marcus. Marcus opened the laptop. The screen lit -- nineteen percent, the number a timer of its own. Marcus navigated to the BioVance files with the quick fingers of a person who knew exactly where the data lived because the data had been his responsibility for three weeks and his responsibility was not something Marcus took lightly.

"BioVance's internal documents reference a twenty-four to forty-eight hour incubation period for airborne exposure. Direct fluid transmission is faster -- six to twelve hours. The pathogen targets the prefrontal cortex first, then spreads to the motor cortex. Higher brain function degrades before motor function, which is why the early-stage infected can still walk and grab and bite while they can no longer speak or reason."

Linda looked at the laptop screen. At the file headers. At the BioVance logo in the corner of the documents. At the clinical data presented in the format that pharmaceutical companies used for internal research -- the format she recognized because she'd read thousands of veterinary pharmaceutical documents in that exact format and the format was the format and the format was real.

"This is internal research documentation," she said. Not a question.

"Extracted from BioVance's servers. I have the complete dataset -- research files, financial records, communications between BioVance executives and Meridian operatives, the deployment timeline, the zone designations."

"And you sent this to the FBI."

"The FBI, the CDC, the EPA, the DOJ, every major news organization in the country. Confirmed delivery. Zero response."

Linda took off her glasses. She cleaned them on her shirt. The cleaning was the mechanical action of a person whose hands needed something to do while her brain processed information that her hands couldn't help with.

"Paul. You were there. In the zone."

"I was in Greenfield, Oregon, for two weeks. I saw infected humans with my own eyes. I treated Kevin's knee -- the injury is consistent with his account of the outbreak. I heard Sacramento radio broadcasting normally while the world two hundred miles north was coming apart. Linda, I wouldn't have called you if I wasn't sure."

"You survived on Purina One."

"Purina One Chicken and Rice Formula. My dogs preferred the Lamb and Rice, but we had to ration."

Linda put her glasses back on. The glasses back on was a decision. The decision was visible -- the physical act of putting the instrument of seeing back on her face because she'd decided to see.

"What do you need from me?" she asked.

The room exhaled. Not literally -- literally, several people continued breathing at the same rate they'd been breathing. But the atmosphere shifted. The atmospheric pressure of a room full of people who'd been pushing against a locked door hearing the door's lock click open.

"We need credibility," Kevin said. "We can't go to the police -- my identity's been flagged. We can't go to the media directly -- they have our data and they've ignored it. We need someone who can carry the message. Someone with institutional credibility. Someone whose name means something to the people who need to hear it."

"You want me to go public."

"I want you to evaluate the data. I want you to apply your professional judgment to the evidence. And then I want you to tell people what your judgment says."

Linda looked at him. The look of a professor evaluating a student's thesis -- not hostile, not sympathetic, just evaluating. Measuring the claims against the evidence. Running the calculations in the background the way Karen ran fuel estimates and Marcus ran decryption algorithms and every person in this room ran the particular equation that their expertise had trained them to run.

"I'll need access to the full dataset. Not a summary. The raw files."

"Marcus."

Marcus turned the laptop toward her. "You have about thirty minutes of battery. I can walk you through the file structure."

"I don't need you to walk me through anything. I can read research documentation." She pulled the chair closer to the desk. Her fingers found the trackpad. She began reading.

---

Linda Yamamoto read for twenty-six minutes. She read the way scientists read -- not front to back, not linearly, but structurally. She found the methodology section first, read the experimental protocols, checked the sample sizes, looked at the control groups. She found the pathogen's genetic sequence and read it like text, the nucleotide pairs scrolling past her eyes with the fluency of a person who read genetic sequences the way other people read email.

Nobody spoke. The room had the quality of a waiting room -- the suspended animation of people who'd presented their case and were waiting for the verdict. Carl ate his second bag of Doritos. Karen watched the parking lot. Rachel sketched in a notebook she'd found in the nightstand drawer, the pen moving in the automatic rhythm of a person who processed stress through her hands.

At the twenty-six-minute mark, Linda looked up from the laptop. The laptop's battery was at six percent. The screen dimmed automatically, the device's own countdown matching the countdown that everything in this room was running against.

"The genetic engineering is real," she said. Her voice had changed. Not louder. Not softer. Denser. The voice of a person who'd evaluated data and reached a conclusion and the conclusion was bad. "The LZR-7 sequence shows deliberate modification of the rabies glycoprotein to enhance neurotropism. The modifications are consistent with gain-of-function research -- the kind that requires BSL-4 containment and federal oversight. The documentation shows neither. This research was conducted outside regulatory frameworks."

"Which means?"

"Which means someone engineered a pathogen that targets the central nervous system with unprecedented efficiency, designed it to maintain motor function while destroying cognitive function, and did it in a lab that wasn't authorized to do it. The result is--" She paused. The pause of a scientist reaching for a word and finding that the accurate word was the word she'd been hoping not to use. "The result is a reanimation pathogen. A virus that produces subjects matching the clinical description of what popular culture calls--"

"Zombies," Paul said.

"I was going to say 'ambulatory post-mortem syndrome.' But yes. The popular term is adequate."

Kevin leaned forward. "Will you help us?"

Linda closed the laptop. The screen went dark. Six percent, five percent, the battery dying while the city slept.

"I have a question first. You said Meridian is staging at Mather Field. That's twenty minutes from where we're sitting. You've been here for--" she checked her watch "--two hours. You've been inside the city for three. You went to the police, got flagged, and came here. You have forty-six hours. What is your actual plan? Not the hope. Not the aspiration. The plan."

Kevin looked at Karen. Karen looked at Kevin. The exchange was the exchange of two people who'd been planning together for three weeks and whose planning language had been compressed into glances and silences and the micro-expressions that developed between people who shared a survival vocabulary.

"We have two tracks," Kevin said. "Track one: warn the public. Get the information to Sacramento's population. If two hundred thousand people know what's coming, Meridian can't deploy in secret. The deployment depends on surprise. Remove the surprise, remove the deployment's viability."

"And track two?"

"Delay or disable the deployment infrastructure at Mather Field. Buy time. Even if we can't stop Meridian permanently, every hour of delay is an hour for evacuation, for federal response, for the information to reach people who can act on it."

"Track two is a military operation against a defense contractor's forward operating base."

"Track two is what Karen does."

Linda looked at Karen. Karen looked back with the neutral expression of a woman who'd been introduced as an accountant and whose accounting was not the kind that involved spreadsheets.

"I'm retired Army," Karen said. The admission was the short version. The long version was classified. The medium version was that "retired Army" meant "retired from a unit that didn't appear in Army organizational charts and whose operations weren't discussed in Congressional hearings." Karen offered the short version because the short version was sufficient and the long version was nobody's business.

"Track one," Linda said. "That's where I come in."

"That's where you come in. You have media access. You have professional credibility. You have a radio show."

"A fifteen-minute spot on Saturday mornings about pet health."

"On a station that broadcasts to a hundred-mile radius."

"A station that's not going to hand over their broadcast to a veterinary professor claiming zombies are coming. Even if I called the station manager right now -- and I know her, Susan Cho, she runs KFBK's programming -- she's not going to interrupt regular broadcasting for this."

"Not yet," Kevin said. "Not tonight. But if we can get corroborating evidence -- something visible, something that Sacramento's people can see for themselves -- then the story has legs. Then it's not a crazy claim from flagged fugitives. It's a credible threat reported by a UC Davis professor with evidence that the public can verify."

"What kind of corroborating evidence?"

"Mather Field. If we can document what Meridian is doing there -- photographs, video, something concrete -- and pair it with the BioVance data, then you have a package. A package that a news station can't ignore."

Linda looked at her hands. The hands of a professor. Clean, manicured, the hands of a woman whose most dangerous professional activity was handling fractious livestock. The hands of a person who was being asked to become something other than what her hands had been trained for.

"I need to see it," she said.

"See what?"

"Mather Field. The staging area. I need to see it with my own eyes. I can present data -- I'm a scientist, I present data for a living. But I can't present data that I haven't verified. If I go on air and claim a defense contractor is staging a bioweapon deployment at a former Air Force base, and it turns out to be a National Guard training exercise, my career is over and your credibility is gone and Sacramento has forty-six hours minus whatever time we've wasted."

"You want to go to Mather Field."

"I want to observe Mather Field. Not infiltrate. Not confront. Observe. From a distance. With binoculars. The same way I observe animal behavior in the field -- from a blind, without disturbing the subjects."

Kevin looked at Karen. Karen's expression had shifted -- not much, a degree or two, the shift from neutral assessment to something that might, in a less controlled person, be called approval.

"I can work with that," Karen said. "A night observation of the perimeter. Small team. Two vehicles. We approach from the east, through the suburban grid. Mather Field's eastern boundary is residential -- houses back up to the old base perimeter. We park in the neighborhood. We walk to the fence. We observe."

"Tonight?" Rachel asked.

"Tonight. We lose six hours if we wait until tomorrow, and six hours is six hours."

Kevin's knee filed its objection. The objection was noted and overruled by the fact that the knee's objection was less important than the deployment's timeline, which was less important than two hundred thousand people's lives, which was the kind of mathematical priority that made a knee's opinion irrelevant even when the knee was right.

"Small team," Kevin said. "Karen, Rachel, and Dr. Yamamoto. Three people. One vehicle. Karen drives. Rachel documents -- she can sketch what she sees, photograph if we can find a camera. Dr. Yamamoto verifies."

"I have a camera," Linda said. "In the car. A Nikon D850. I use it for field research documentation."

"A vet with a professional camera," Marcus said.

"A vet who photographs wildlife disease manifestations for journal publications. High-resolution, low-light capable. I photograph lesions on cattle at three in the morning. I can photograph a staging area."

Kevin looked at the group. Nine people in a motel room, plus one veterinary professor with a Nikon, plus forty-six hours, plus whatever was waiting at Mather Field.

"Go," Kevin said. "Observe only. No contact. If you see something that confirms the staging area, photograph it and come back. If you see something that doesn't confirm it--"

"Then we have a different problem," Linda said. "But we won't. Because Paul doesn't call me at nine o'clock on a Tuesday night for things that aren't real."

She stood. She looked at Paul. Paul looked at her with the expression of a man whose professional network had just become a survival network and whose survival depended on a woman he'd met at a conference on bovine tuberculosis fifteen years ago.

"Be careful," Paul said.

"I photograph angry bulls for a living. I'll be fine." She looked at Karen. "Your car or mine?"

"Mine. The Prius is too quiet. We need engine noise to mask our approach."

"A Ford F-250 is too quiet?"

"In a residential neighborhood at night, an electric car is conspicuous. An old truck is background noise."

Linda considered this. The consideration of a woman applying new criteria to a familiar object -- her Prius, which she'd chosen for fuel efficiency and environmental responsibility and which was now being evaluated for its tactical profile by a woman who evaluated things for their tactical profile the way Linda evaluated them for their environmental impact.

"Your car," Linda agreed.

Karen was already moving. Rachel was already moving. The two women who moved first and thought in parallel and whose movement was the movement of people whose bodies had learned to respond to decisions before the decisions were fully spoken.

They left. The F-250's engine started. The headlights swept across the parking lot. The truck pulled out onto Watt Avenue and turned east, toward Mather Field, toward the evidence that would either confirm everything or make everything worse.

Kevin sat on the motel bed. His leg was elevated. His stick was beside him. The room was smaller now -- six people instead of ten, the absence of Karen and Rachel and Linda creating a space that felt less like a reduction and more like a subtraction, the removal of the people whose presence made the room feel like something could be done.

Paul sat on the other bed. Chester was in his lap. Maggie was asleep beside Derek in the next room, and Derek was asleep beside Maggie, the two of them unconscious in the synchronicity of a man and a dog who'd found each other thirty-six hours ago and whose sleep schedules had already merged.

"Do you trust her?" Kevin asked Paul. "Not professionally. Personally."

Paul stroked Chester's ears. The beagle leaned into the touch with the commitment of a dog whose entire philosophy could be summarized as "more of this."

"She published a paper in 2019 on prion disease transmission in cervid populations. The paper contradicted the USDA's official position. The USDA pressured UC Davis to retract. Linda told the USDA to retract their policy instead, published the data independently, and testified before a state agricultural committee. The committee changed the policy. The USDA issued a correction six months later."

"So she's--"

"She's the person who tells the truth to institutions that don't want to hear it. That's why I called her. That's exactly what we need."

Kevin looked at the door. At the parking lot beyond it. At the city beyond that -- a city of streetlights and stop signs and people sleeping in beds in houses that had locks on the doors and alarms on the windows and none of it, none of the security, none of the infrastructure, none of the systems that these people had built to protect themselves, would stop what was coming.

He picked up the motel phone. He dialed Marcus's extension in the next room.

"Marcus. The laptop's dying. Is there any way to charge it?"

"I found an outlet behind the TV. I'm charging now. Should be at fifty percent by midnight."

"Good. When Karen gets back, I need the Meridian intercepts ready. Everything you've decoded. Can you organize it into something a news producer could understand?"

"I can organize it into something a golden retriever could understand. News producer should be easy."

"Do it."

Kevin hung up. He lay back on the bed. The bed was soft. The bed was the softest thing he'd touched in three weeks -- a mattress, a real mattress, with sheets and a pillow and the engineered comfort of a hospitality industry that existed because people paid money to sleep in places that weren't their homes. The luxury of a bad mattress in a cheap motel, and the luxury was real, and the luxury was temporary, and the temporary was forty-six hours.

He closed his eyes. He didn't sleep. He lay in the dark of a motel room in a city that was alive and counted the hours backward from the number that mattered.

Forty-six. Forty-five. Forty-four.

Outside, the F-250 drove east through the suburbs, carrying two women and a scientist toward a former Air Force base where a defense contractor was preparing to end the world, and the suburbs it drove through were lit and warm and had no idea that the truck contained the only people trying to stop it.